Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues by Zhou, J et al.
Transcriptome Pathway Analysis of Pathological and Physiological
Aldosterone-Producing Human Tissues
ZHOU, J; Lam, B; Neogi, SG; Yeo, GSH; Azizan, EAB; Brown, MJ
 
 
 
 
 
© 2016 The Authors.
Hypertension is published on behalf of the American Heart Association, Inc., by Wolters
Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution, and reproduction in any medium,
provided that the original work is properly cited.
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/16300
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
1Primary aldosteronism (PA) is estimated to occur in 10% 
of all hypertensive patients.1 Excessive aldosterone in PA 
patients not only causes hypertension but also brings detri-
mental effects to multiple systems independent of the blood 
pressure level.2,3 Hypertension (and PA) caused by a unilat-
eral aldosterone-producing adenoma (APA) can be cured 
or markedly improved by unilateral adrenalectomy. Recent 
interest in this common, multiple impact, potentially cur-
able syndrome has led to major advances in the molecular 
understanding of PA. Somatic mutations in the KCNJ5 gene 
have been found associated with classical zona fasciculata 
(ZF)–like APAs, whereas somatic mutations in ATP1A1, 
CACNA1D, CTNNB1, and ATP2B3 have in some studies 
been found associated with zona glomerulosa (ZG)–like 
APAs and aldosterone-producing cell clusters (APCCs).4–6 
Despite identification of these specific causal mutations, 
the pathways involved with APA formation in the adrenal 
remain unclear.
The adrenal ZG is the only physiological site for aldoste-
rone production, whereas the ZF and zona reticularis produce 
glucocorticoids and sex steroids. Therefore, the 3 adrenocor-
tical zones, and the adrenal medulla (which has a different 
embryological origin), would have different transcriptome 
profiles and signaling pathways. Yet previous profiling of 
APA transcriptomes used as reference whole normal adre-
nal or whole adrenal cortex without separating the different 
zones.7–14 As an improvement, one study compared a single 
APA with its adjacent ZG through peeling the capsule (and 
ZG) from the ZF with a pair of forceps.15 However, as human 
ZG (unlike rodent ZG) is discontinuous, the ZG sample from 
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this study would have included some ZF cells and the adrenal 
capsule (ie, fibroblast cells). Hence, ZG cells must be discrim-
inated from ZF cells carefully before sampling.
One method of discriminating ZG described by 
Nishimoto et al4 in human adrenal from kidney donors was 
through immunohistochemistry staining with a CYP11B2 
antisera. However, this method samples only aldosterone-
producing ZG cells. To select unbiasedly all ZG cells, we 
developed a method to differentiate the human ZG from ZF 
using cresyl violet (previously used by Nishimoto et al16 in 
rats).17 This allowed for the comparison of the pathological 
aldosterone-producing tissue, the APA, to the physiological 
capable aldosterone-producing tissue, the ZG, and compari-
son of the ZG with the physiological capable cortisol-pro-
ducing tissue, the ZF. Comparisons were made between ZG 
and ZF adjacent to an APA and adjacent to a phaeochro-
mocytoma. This study design accurately identified previ-
ously unknown ZG genes, which were functionally shown 
to regulate aldosterone.17–19 Herein, we highlight aberrantly 
activated or suppressed biological processes and pathways 
associated with genes differentially regulated between the 
ZG and APA and analyzed the gene expression profile of 
adrenals harboring the most common somatic mutation in 
APAs, the KCNJ5 mutation.5,20,21
Methods
Sample Acquisition
Laser capture microdissected samples from the ZG, ZF, and APA were 
obtained from the adrenals of 14 patients with an APA and 7 patients with 
a phaeochromocytoma as previously described.17,22 Diagnosis of APA 
was confirmed through immunohistochemistry of CYP11B2 as detailed 
in Figure S1 in the online-only Data Supplement. Extracted RNA quality 
was determined using an Agilent Bioanalyzer 2100 (Pico) and only RNA 
with a RIN≥7 was used for microarray analysis. Confirmation of selec-
tive sample acquisition was done through corticosteroid gene expression 
profiling (details provided in the Figure S2). In total, paired ZG, ZF, 
and APA samples were collected from 7 KCNJ5-mutant patients, 7 
KCNJ5 wild-type patients, and 7 phaeochromocytoma patients. The 
clinical features of these patients are detailed in Table S1.
Microarray Analysis
The 56 RNA samples acquired through laser capture microdissec-
tion were loaded onto the Affymetrix Human Gene 1.0 ST Arrays at 
the Genomics Corelab, Cambridge as previously described.17 The 
microarray result is deposited in the Gene Expression Omnibus 
database (GSE64957). Validation by quantitative polymerase chain 
reaction was performed for genes with fold-change >10 and ste-
roidogenic enzymes CYP11B2, CYP11B1, and CYP17A1 using 
standard and validated23 custom-made Taqman gene expression 
assays (AppliedBiosystems). Results were analyzed using the 
2-ΔΔCT method with 18S rRNA as the endogenous control.
Statistical Analysis
The array data were normalized using robust multiarray aver-
age and differentially expressed genes were identified as previ-
ously described.17 Genes with a fold-change >2 and P<0.05 were 
imported into AmiGO 224 for PANTHER (Protein Analysis Through 
Evolutionary Relationships) over-representation test of GO biologi-
cal processes (experimental only) using the GO ontology database 
(release 20150430) and imported into Ingenuity Pathway Analysis 
(Qiagen Redwood City, CA) for pathway enrichment and top molecu-
lar and cellular functions. The P value of these analyses was deter-
mined based on the number of genes differentially expressed in each 
process or pathway.
Results
APA Versus ZG
GO Analysis
To identify the independent alterations of steroidogenesis 
responsible for PA, gene expression in the pathological aldo-
sterone-producing tissue, the APA, was compared with the 
reference tissue also differentiated for aldosterone production, 
the ZG. A total of 277 genes were differentially expressed by 
>2 fold, of which 104 were upregulated and 173 were down-
regulated (P<0.05).
GO analysis of these 277 genes showed an enrichment of 
biological processes terms related to genes associated with 
steroid, alcohol, and organic hydroxy compound metabolic 
processes, genes associated with cell migration and angiogen-
esis, and genes associated with the regulation of body fluid 
levels (Table 1).
Genes that were associated with steroid, alcohol, and 
organic hydroxy compound metabolic processes that were 
upregulated in APA versus ZG were downregulated in ZG 
versus ZF, and vice versa (Table S2). A similar trend was seen 
in genes associated with cell migration and angiogenesis and 
genes associated with regulation of body fluid levels (Tables 
S3 and S4). The top 10 genes that were downregulated in APA 
versus ZG overlapped with the top 10 genes upregulated in 
ZG versus ZF (ie, LGR5, ANO4, VCAN, and SFRP4 as shown 
in Tables S5 and S6). Further analysis found 108 of the 173 
genes that were downregulated in APAs versus ZG were 
upregulated in ZG versus ZF.
Pathway Analysis
The top 5 canonical pathways enriched in APA versus ZG were 
NRF2-mediated oxidative stress response, complement sys-
tem, lipopolysaccharide (LPS)/interleukin-1 (IL-1)–mediated 
inhibition of retinoid X receptor (RXR) function, glucocorti-
coid biosynthesis, and androgen biosynthesis (Table 2).
The top molecular and cellular functions in APAs (ver-
sus ZG), cell death and survival, lipid metabolism, and 
Table 1. GO Terms of Biological Processes ≥5-Fold-Enriched 
in Aldosterone-Producing Adenoma Compared With Zona 
Glomerulosa
GO Biological Processes P Value
Steroid metabolic process 1.44×10−3
Alcohol metabolic process 2.10×10−3
Blood vessel endothelial cell migration 4.35×10−3
Cell migration 4.70×10−3
Endothelial cell migration 8.38×10−3
Regulation of body fluid levels 9.99×10−3
Organic hydroxy compound metabolic process 1.96×10−2
Organic hydroxy compound transport 3.33×10−2
Epithelium migration 3.86×10−2
Tissue migration 3.86×10−2
Epithelial cell migration 3.86×10−2
Cell migration involved in sprouting angiogenesis 4.99×10−2
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small-molecule biochemistry, overlapped with the top 
molecular and cellular functions enriched in ZG (versus ZF; 
Table 3). No overlap was seen for cellular growth and pro-
liferation and cellular movement. The molecular and cellular 
functions, vitamin and mineral metabolism, and molecular 
transport were uniquely enriched in genes differentially reg-
ulated in ZG versus ZF.
APAs were also separately compared with ZG samples 
adjacent to a phaeochromocytoma only. Six of the top 10 
genes (up- and downregulated) and all the top 5 molecular 
and cellular functions were the same as identified when 
comparing APA with all ZG samples (Tables S7 and S8, 
respectively). Similarly, LPS/IL-1–mediated inhibition of 
RXR function was highlighted as 1 of the top 5 canonical 
pathways regardless of whether APA was compared with all 
ZG samples or phaeochromocytoma samples only (Table 2; 
Table S9).
ZG Versus ZF
GO Analysis
A total of 334 genes were differentially expressed by >2-
fold when comparing all ZG samples with all ZF samples, of 
which 213 were upregulated and 121 were downregulated in 
ZG (P<0.05). GO analysis of these genes showed an enrich-
ment of terms related to steroid, cholesterol, lipid, lipoprotein, 
alcohol biological processes, and terms related to Wnt signal-
ing (Table 4). Similar to genes associated with steroid, organic 
hydroxy compound, and alcohol-related processes (Table S2), 
8 genes associated with the Wnt signaling pathway that were 
upregulated in ZG versus ZF were downregulated in APA ver-
sus ZG (Table S10).
The enrichment of biological processes terms related to 
genes associated with steroid, cholesterol, lipid, lipoprotein, 
alcohol-related processes, and genes associated with the Wnt 
signaling pathway remained true irrespective of whether the 
comparison was made separately for ZG adjacent to an APA 
or a phaeochromocytoma (Tables S10–S13). In agreement, 
165 of the genes upregulated and 76 of the genes downregu-
lated in ZG were the same when comparing all ZG samples 
with all ZF samples or when comparing samples from phaeo-
chromocytoma patients only. Of the top 10 genes upregulated 
in all ZG samples, 8 remained the same when only comparing 
samples from pheochromocytoma patients (Table S6). All of 
the genes, but 2 (ITGA3 and GRB10), associated with the Wnt 
signaling pathway were upregulated in ZG versus ZF samples, 
irrespective of whether the comparison was made separately 
for ZG adjacent to an APA or a phaeochromocytoma (Tables 
S10 and S11).
Table 2. Top 5 Canonical Pathways Associated With Genes 
Differentially Regulated in APA Compared With ZG and ZG 
Compared With ZF
 Overlap P Value
Top canonical pathways in APA vs ZG 
  NRF2-mediated oxidative stress response 10/180 7.9×10−5
   Complement system 5/37 8.4×10−5
  LPS/IL-1–mediated inhibition of RXR function 11/219 8.6×10−5
   Glucocorticoid biosynthesis 3/13 4.8×10−4
   Androgen biosynthesis 3/15 7.4×10−4
Top canonical pathways in ZG vs ZF 
  LPS/IL-1–mediated inhibition of RXR function 20/219 6.5×10−11
   FXR/RXR activation 14/127 4.4×10−9
   LXR/RXR activation 11/121 1.5×10−6
  NRF2-mediated oxidative stress response 13/180 2.2×10−6
   Xenobiotic metabolism signaling 15/271 1.0×10−5
FXR indicates farnesoid X receptor; IL-1, interleukin-1; LPS, lipopolysaccharide; 
LXR, liver X receptor; RXR, retinoid X receptor; ZG, zona glomerulosa; and ZF, zona 
fasciculata.
Table 3. Top 5 Molecular and Cellular Functions Enriched 
in APA (Compared With ZG) and in ZG (Compared With Zona 
Fasciculata)
 Molecules P Value
Top APA molecular and cellular functions
  Cell death and survival 114 1.4×10−4–8.5×10−15
   Cellular growth and 
proliferation
117 1.5×10−4–1.1×10−13
   Cellular movement 83 1.1×10−4–2.0×10−12
  Lipid metabolism 72 1.5×10−4–2.1×10−12
 Small molecule biochemistry 79 1.5×10−4–2.1×10−12
Top ZG molecular and cellular functions
  Lipid metabolism 85 2.3×10−4–6.0×10−17
  Small molecule biochemistry 98 2.3×10−4–6.0×10−17
   Vitamin and mineral 
metabolism
40 1.0×10−4–6.0×10−17
  Cell death and survival 131 2.1×10−4–1.0×10−16
   Molecular transport 101 2.3×10−4–5.3×10−16
APA indicates aldosterone producing adenoma; and ZG, zona glomerulosa.
Table 4. GO Terms of Biological Processes ≥5-Fold Enriched 
in Zona Glomerulosa Compared With Zona Fasciculata
GO Biological Processes P Value
Negative regulation of steroid biosynthetic process 2.45×10−2
Negative regulation of steroid metabolic process 2.45×10−2
Cholesterol efflux 4.18×10−2
Negative regulation of lipid biosynthetic process 7.27×10−3
Regulation of plasma lipoprotein particle levels 2.13×10−2
Negative regulation of Wnt signaling pathway 5.59×10−4
Steroid metabolic process 5.59×10−4
Negative regulation of canonical Wnt signaling pathway 1.02×10−2
Regulation of lipid biosynthetic process 4.40×10−2
Regulation of canonical Wnt signaling pathway 7.48×10−4
Regulation of Wnt signaling pathway 7.64×10−6
Alcohol metabolic process 9.06×10−3
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However, some genes associated with steroid, organic 
hydroxy compound, and alcohol-related processes that 
were upregulated in ZG samples from phaeochromocy-
toma patients (eg, CYP11B2, CYP39A1, PLA2G1B, and 
SULT1E1), were not significantly upregulated in ZG samples 
from adrenals with an APA (Table S12). Comparing the bio-
logical processes enriched in ZG versus ZF, we found that 
negative regulation of steroid biosynthetic process, negative 
regulation of steroid metabolic process, cholesterol efflux, 
negative regulation of lipid biosynthetic process, and regula-
tion of plasma lipoprotein particle levels did not occur when 
only comparing samples adjacent to a phaeochromocytoma 
(Table 4; Table S13).
Pathway Analysis
Pathway analysis of genes differentially regulated in ZG (ver-
sus ZF) highlighted the same canonical pathways as that with 
APAs versus ZG: NRF2-mediated oxidative stress response 
and LPS/IL-1–mediated inhibition of RXR function (Table 3). 
FXR/RXR activation, LXR/RXR activation, and xenobiotic 
metabolism signaling pathways were uniquely affected in ZG 
(versus ZF). LPS/IL-1–mediated inhibition of RXR function 
remained the top canonical pathway affected even when only 
interrogating ZG samples adjacent to a phaeochromocytoma 
(Table S14).
Thirteen genes involved in the NRF2-mediated oxida-
tive stress response canonical pathway were differentially 
expressed in ZG versus ZF, of which 10 were also differ-
entially expressed in APA versus ZG (Figure 1; details in 
Table S15). The most differentially expressed in APA versus 
ZG were FBJ murine osteosarcoma viral oncogene homo-
log B (FOSB) and FBJ murine osteosarcoma viral oncogene 
homolog (FOS), both with an ≈6-fold-change. The most 
differentially expressed in ZG versus ZF were glutathione 
S-transferase alpha 1 (GSTA1) and glutathione S-transferase 
alpha 3 (GSTA3), with an ≈21-fold-change and a 9-fold-
change, respectively.
Twenty genes involved in the LPS/IL-1–mediated inhi-
bition of RXR function canonical pathway were differen-
tially expressed in ZG versus ZF, of which 11 were also 
differentially expressed in APA versus ZG (Figure 2; details 
in Table S16). Among the most differentially expressed 
genes in this pathway were once again GSTA1 and GSTA3, 
and sulfotransferase family 2A member 1 (SULT2A1), 
which was 8.21-fold downregulated in ZG compared with 
ZF and the most upregulated (11.08-fold) in APA compared 
with ZG (Table S16).
KCNJ5 Genotypes
Comparing KCNJ5 mutation status, 138 genes were differ-
entially expressed in mutant APAs versus KCNJ5 wild-type 
APAs, of which 61 genes were upregulated (fold-change >2; 
P<0.05). ACSS3, encoding the enzyme that synthesizes acetyl-
CoA, an important precursor of cholesterol, was the top gene 
upregulated in KCNJ5-mutant APAs compared with wild-type 
ones. Interestingly, NEFM (encoding the neurofilament triplet 
M protein), a gene previously validated by quantitative poly-
merase chain reaction to be almost 200-fold upregulated in 
ZG (versus ZF),17 was upregulated in KCNJ5 wild-type APAs 
(versus mutant APAs; Tables S6 and S17).
Comparing ZG samples adjacent to a KCNJ5-mutant APA 
or a wild-type APA, 56 genes were differentially expressed of 
which 30 genes were upregulated (fold-change >2; P<0.05). 
The top 10 differentially regulated genes are shown in Table 
S18.
Figure 1. Genes associated with the NRF2-mediated oxidative stress response pathway that were differentially regulated in aldosterone-
producing adenoma (APA) vs zona glomerulosa (ZG) and ZG vs zona fasciculata (ZF).
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Comparing ZF samples in a similar manner, 59 genes 
were differentially expressed of which 38 genes were upregu-
lated in ZF samples adjacent to a KCNJ5-mutant APA (fold-
change >2; P<0.05). Surprisingly, NR4A2 (the transcription 
factor of CYP11B2) was found to be the most upregulated 
gene (Table S19). Validation by quantitative polymerase chain 
reaction showed >50-fold higher NR4A2 mRNA expres-
sion in ZF samples adjacent to a KCNJ5-mutant APA than 
those adjacent to KCNJ5 wild-type APA (n=6; P=0.007).
Molecular and cell function analysis suggested some dif-
ferences between APAs with different KCNJ5 genotypes, 
and in the ZF samples adjacent to them (Table S20). In 
contrast, little difference (<10 genes affected per function) 
was found between ZG samples adjacent to APAs with dif-
ferent KCNJ5 genotypes (Table S20). Similarly, canonical 
pathway analysis found little difference between samples 
from patients with different genotype, all with a P>1.0×10–3 
(Table S21). No significant enrichments of GO biological 
processes terms were found.
Discussion
This study performed GO and pathway analyses on genes 
expressed in APAs and ZG—one a pathological aldosterone-
producing tissue and the other a physiological aldosterone-
producing tissue. Previous transcriptomic studies comparing 
APAs with normal adrenal glands unavoidably selects ZF, 
the major component of the adrenal cortex, as their reference 
samples.7–13,23,25–28 As the ZF is not physiologically capable 
of producing aldosterone, such comparisons would be diffi-
cult to interpret when seeking to understand the pathologi-
cal mechanism of autonomous aldosterone production in 
APAs. Despite the disadvantage of previous transcriptomic 
studies, many pathways associated with aldosterone regula-
tion have been identified to be aberrantly activated or sup-
pressed in APAs: the Wnt/β-catenin signaling pathway, the 
PI3K/AKT signaling pathway, the MAPK signaling pathway, 
and the calcium signaling pathway.12,13,15,29 Genes found dif-
ferentially expressed in the APA compared with normal adre-
nal includes G-protein–coupled hormone receptors such as 
GnRH, GPR37, GRM3, LH, AVP, and HTR47,8,10,11,30 and ste-
roid enzymes such as CYP11B2, CYP11B1, CYP17A1, and 
StAR. In our comparison between APA and ZG, most of the 
top genes were not reported before to be associated with PA. 
Similarly, the most significant pathways enriched in both 
APAs (versus ZG) and ZG (versus ZF), the NRF2-mediated 
oxidative stress response and the LPS/IL-1–mediated inhibi-
tion of RXR function pathways, had not been highlighted in 
past transcriptomic studies. We postulate the differences seen 
in our findings are because of our differentiation of the adre-
nal cortex transcriptomes to transcriptomes from the ZG and 
transcriptomes from the ZF.
NRF2-mediated oxidative stress response pathway is an 
important pathway for cell survival as severe oxidative stress 
can activate apoptosis and necrosis. This pathway has been 
associated with oxidative stress-mediated diseases such as can-
cer, neurodegenerative, cardiovascular and pulmonary compli-
cations.31 The pathway involves binding of NRF2 to antioxidant 
response elements, which activates their transcription. The role 
of this pathway in PA is supported by recent findings of increased 
oxidative stress in PA patients measured by high NADPH oxi-
dase (nicotinamide adenine dinucleotide phosphate–oxidase; 
Nox2-dp) plasma levels and urinary isoprostanes preadrenalec-
tomy32 and the previous finding in a single APA of increased 
expression of oxidative stress–related proteins.33 As oxidative 
stress mediates genotoxic effects,34 and oxidative damage is 
postulated to occur in the adrenal,35 the findings of >50% of 
APAs pathological aldosterone production due to a somatic 
mutation5,20,21 collectively suggest that oxidative stress could be 
involved in mediating DNA damage in driver genes resulting in 
the pathological corticosteroid production.
Figure 2. Genes associated with the lipopolysaccharide (LPS)/interleukin-1 (IL-1)–mediated inhibition of retinoid X receptor (RXR) function 
pathway that were differentially regulated in aldosterone-producing adenoma (APA) vs zona glomerulosa (ZG) and ZG vs zona fasciculata 
(ZF). CAR indicates constitutive androstane receptor; and RAR indicates retinoic acid receptor.
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Of the 2 overlapping pathways, only LPS/IL-1–mediated 
inhibition of RXR (retinoid X receptor) function pathway 
remained affected when only comparing ZG samples adja-
cent to a phaeochromocytoma (Tables S9 and S14). RXR is a 
ligand-dependent nuclear receptor that forms a complex with 
other ligand-dependent nuclear receptors and affects tran-
scriptional receptors.36 LPS and IL-1 can trigger the inhibi-
tion of this transcriptional cassette.37 It has been reported that 
the reduction of proteins related to the LPS/IL-1–mediated 
inhibition of RXR function pathway can lead to impaired 
metabolism, transport or biosynthesis of lipid, cholesterol, 
bile acid, and xenobiotics.38,39 In APAs, genes related to this 
pathway were mainly upregulated, suggesting perhaps a role 
in the metabolism, transport, and biosynthesis of cholesterol, 
a key precursor of aldosterone. On the contrary, genes asso-
ciated with this pathway were downregulated in ZG (Table 
S16), suggesting decrease of corticosteroid synthesis, which is 
in agreement with our previous finding of ZG selective genes 
regulating aldosterone negatively and the low patchy staining 
of CYP11B2 in ZG.17–19
One pathway that had already been associated previously 
with aldosterone regulation is the Wnt signaling pathway. A 
transcriptomic study in rodents found 3 Wnt-related proteins 
enriched in rat ZG: CPZ, GPC3, and WNT4.40 We similarly 
found an enrichment of GO terms related to the Wnt signaling 
pathway when comparing human ZG with ZF. However, inves-
tigation in human adrenal cells found LGR5 (the most upregu-
lated Wnt-related ZG-gene in humans) to reduce aldosterone 
production and CYP11B2 mRNA expression, increase apop-
tosis, and reduce proliferation,18 whereas WNT4 deficiency in 
mice reduced aldosterone production and CYP11B2 mRNA 
expression,41 and constitutive β-catenin activation caused the 
development of PA and promoted malignancy.42 Interestingly, 
LGR5 has also been observed to be downregulated in APCCs 
compared with ZG in human adrenals from kidney donors.4
The opposite findings from humans and rodents could 
be without significance and ascribed to random species 
variation. In agreement, little overlap was found between the 
most upregulated genes in ZG from the rodent study16,40 and 
our human study (only 3 of the top 50: RGS4, ATP10A, and 
PDE2A),17 and similarly different potassium channels were 
found to dominate the ZG K+ currents in the 2 species.43 In 
addition, we speculate that some of the species variation 
could be a result of human’s chronic exposure to salt. We 
hypothesize, in chronic salt environment, that the ZG cells in 
human adrenals undergo apoptosis when not producing aldo-
sterone. This hypothesis is based on (1) CYP11B2−/− mice, 
where ZG cells migrate and apoptose,44 (2) the disappear-
ance from most of human ZG of CYP11B2, which became 
apparent with selective antisera,45 (3) well-known suppres-
sion of renin–aldosterone production by salt excess, (4) our 
own apoptosis data in human ZG.18 Thus, rodents may not 
be ideal models for PA (or even physiological production 
of aldosterone), and a human model, such as our microarray 
study, is needed to specifically understand the regulation of 
aldosterone in humans.
Our earlier microarray comparing KCNJ5-mutant APAs 
with ATP1A1- or CACNA1D-mutant APAs (all wild-type 
for KCNJ5) identified 43 genes differentially regulated 
(fold-change >2; false discovery rate <0.05).6 In our current 
microarray, we found the difference between KCNJ5-mutant 
and KCNJ5 wild-type APAs to be much smaller. Although 
138 genes were differentially regulated (fold-change >2; 
P<0.05), none passed the false discovery rate <0.05 thresh-
old. Nevertheless, we did once again find MYOM1, BEX1, 
VPREB3, NETO2, and PTPRZ1 to be differentially regulated 
(fold-change >2; P<0.05), as previously published when 
comparing CACNA1D/ATP1A1 mutant APAs with KCNJ5-
mutant APAs (Table S14).6 Thus, although tissues with dif-
ferent genotypes have similar transcriptome profiles, some 
key marginal differences do exist between differing KCNJ5 
genotypes. For example, ACSS3 was the top upregulated gene 
in KCNJ5-mutant APA. The encoded protein ligates acetate 
and CoA to make acetyl-CoA, the sole carbon source and 
precursor for both fatty acid and cholesterol biosynthesis in 
mammalian cells. Therefore, it could potentially be the rea-
son for the high aldosterone production seen in patients with 
KCNJ5-mutant APAs despite the low expression of CYP11B2 
in the adenoma.46
Another key difference was NEFM, a highly selective 
ZG-gene that was upregulated in KCNJ5 wild-type APAs 
compared with mutant APAs (Tables S6 and S14). We had 
previously reported another ZG selective gene, nephronec-
tin (NPNT), to be significantly upregulated in ATP1A1- or 
CACNA1D-mutant APAs compared with KCNJ5-mutant 
APAs.6 This may be seen as an unbiased support for our cur-
rent paradigm that KCNJ5-mutant APAs (unlike ATP1A1 
and CACNA1D-mutant APAs) are ZF like and may have 
arisen from the cortisol-producing ZF instead of ZG.22 In 
further support of this proposition, NR4A2, the transcrip-
tion factor for aldosterone production, was the most highly 
expressed gene in ZF adjacent to a KCNJ5-mutant APA (ver-
sus wild-type ZF; Table S19). However, additional studies 
are warranted in interrogating the origin and formation of 
these APAs especially because APCCs, whom some propose 
are precursors of APAs, can be present in ZF, and APCCs 
have a high rate of mutation in CACNA1D and ATP1A1 but 
not in KCNJ5.4
The strengths of the study of comparing APA samples with 
adjacent ZG are also the limitations of this study. These ZG 
samples would have aldosterone production suppressed by the 
paracrine effect of the APA. Therefore, we have supplemented 
our data with APA versus phaeochromocytoma although these 
also may have their own paracrine effect of the adenoma.47 
Considering that the reported difference of CYP11B2 
expression in normal ZG versus ZF, harvested from healthy 
renal transplantation donors, is also only about 2-fold (as 
seen by the microarray results for the four ZG samples),4 it 
seems that the aldosterone production in human ZG, whether 
normal or adjacent to a pheochromocytoma or an APA, is 
suppressed. Furthermore, our method of undiscriminatory 
sampling of ZG cells prevents enrichment of populations of 
aldosterone-producing ZG cells or knowledge of samples 
containing APCCs. We are reassured, however, that a quick 
comparison of the top ZG genes (eg, LGR5) suggests that the 
transcriptomes of our ZG samples are different from APCCs 
and more similar to ZG samples acquired from the adrenal 
of kidney donors.4
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Perspectives
We have identified a list of novel genes and canonical path-
ways enriched in pathological and physiological aldosterone-
producing human tissues. Through exploring the role of these 
highlighted genes and pathways on aldosterone production, 
the molecular mechanism of APA formation and pathology 
could potentially be unraveled further.
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What Is New?
•	We performed gene ontology and pathway analysis on transcriptome pro-
files of laser capture microdissected paired human aldosterone-produc-
ing adenoma (APA), zona glomerulosa (ZG), and zona fasciculata samples.
What Is Relevant?
•	We identified a list of novel genes, biological processes, and canonical 
pathways that may be involved with APA pathology and ZG cell functions. 
We also investigated the effect of the most common somatic mutation 
(KCNJ5) in APA, ZG, and zona fasciculata tissues, respectively.
Summary
Comparison of transcriptomes from an APA, a pathological aldo-
sterone-producing tissue, and ZG, a physiological aldosterone- 
producing tissue, identified steroid metabolic processes, Wnt 
signaling pathway, NRF2-mediated oxidative stress response 
pathway, LPS (lipopolysaccharide)/IL-1 (interleukin-1)–mediated 
inhibition of RXR function to play a role in aldosterone regulation. 
Comparison of tissue samples by the presence of a KCNJ5-mu-
tant APA found (1) ACSS3, encoding the enzyme that synthesizes 
acetyl-CoA, to be upregulated in KCNJ5-mutant APAs; (2) NEFM, a 
gene highly upregulated in ZG, to be upregulated in KCNJ5 wild-
type APAs; and (3) NR4A2, the transcription factor for aldosterone 
synthase, to be highly expressed in zona fasciculata adjacent to a 
KCNJ5-mutant APA. These genes and pathways could potentially 
provide further insights into the pathology of PA.
Novelty and Significance
